Eli Lilly has won FDA approval for its oral obesity drug Foundayo™ (orforglipron), but the stock bounce was short lived as investors pondered how much in sales it will generate this year as a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results